A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany. [electronic resource]

By: Contributor(s): Producer: 20170329Description: 599-606 p. digitalISSN:
  • 1439-0973
Subject(s): Online resources: In: Infection vol. 44
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.